Fig. 1: Molecular subgroups within EBV-/MSS gastric cancer in patients from the Dutch D1/D2 trial.

Numbers and proportions of the four molecular subgroups are indicated. EBV-/MSS Epstein-Barr virus negative and microsatellite instable, GS genomically stable, CIN chromosomal instable.